Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Novan, Inc. (NOVN)
|
Add to portfolio |
|
|
Price: |
$1.33
| | Metrics |
OS: |
28.0
|
M
| |
|
|
Market cap: |
$37.3
|
M
| |
|
|
Net cash:
|
$12.5
|
M
| |
$0.45
|
per share
|
EV:
|
$24.7
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($37.7)
|
M
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 3.0 | 4.9 | 4.9 | 6.0 | 2.6 | 0.0 | 0.0 | 0.1 |
Revenue growth | -39.9% | 0.5% | -18.3% | 126.4% | | | -100.0% | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 3.0 | 4.9 | 4.9 | 6.0 | 2.6 | 0.0 | 0.0 | 0.1 |
Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | | 100.0% |
Research and development | 20.4 | 19.8 | 25.2 | 23.0 | 25.2 | 46.5 | 16.6 | 6.8 |
General and administrative | 12.3 | 11.3 | 10.4 | 11.5 | 13.1 | 13.3 | 9.3 | 5.2 |
EBIT | -29.9 | -28.4 | -30.7 | -28.6 | -35.7 | -59.8 | -25.8 | -11.8 |
EBIT margin | -1011.3% | -578.1% | -626.8% | -476.7% | -1348.4% | | | -10560.7% |
Pre-tax income | -29.7 | -29.3 | -30.4 | -29.2 | -36.6 | -59.7 | -25.8 | -13.1 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Earnings from continuing ops | -29.7 | -29.3 | -30.4 | -29.2 | -36.6 | -59.7 | -25.8 | -13.1 |
Earnings from discontinued ops | | | | | | | -2.3 | 1.7 |
Net income | -29.7 | -29.3 | -30.4 | -29.2 | -36.6 | -59.7 | -28.1 | -11.4 |
Net margin | -1003.8% | -595.4% | -620.4% | -488.0% | -1384.0% | | | -10167.9% |
|
Diluted EPS | ($1.74) | ($2.96) | ($1.16) | ($1.13) | ($2.29) | ($9.97) | ($11.36) | ($5.95) |
Shares outstanding (diluted) | 17.1 | 9.9 | 26.3 | 25.8 | 16.0 | 6.0 | 2.3 | 2.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|